© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to January
oral CFTR ABC transporter potentiator
Ph. II for cystic fibrosis (5-80 mg QD), discont.
similarity screen of 589 cmpds + scaffold hop
J. Med. Chem., Jan. 5, 2021
Galapagos NV, Mechelen, BE
The Galapagos CFTR potentiator, GLPG2451, is an oral, once-daily clinical candidate for cystic fibrosis (5-80 mg QD). It was advanced into a high-profile Ph. II triple-combo study with the…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.